St. Jude's device used in stenting procedures gets FDA OK

10/23/2013 | (Boston)

St. Jude Medical has received premarket approval from the FDA for its Ilumien Optis system. The next-generation device uses a combination of optical coherence tomography and fractional flow reserve technology to allow surgeons to monitor blood flow and visualize the heart during stenting procedures.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID